Australia markets open in 1 hour 41 minutes

Liaoning He Eye Hospital Group Co., LTD. (301103.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
26.15+0.16 (+0.62%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 4.13B
Enterprise value 2.81B
Trailing P/E 115.71
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.55
Price/book (mrq)1.99
Enterprise value/revenue 2.42
Enterprise value/EBITDA 35.06

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-37.94%
S&P500 52-week change 325.77%
52-week high 348.99
52-week low 319.97
50-day moving average 325.72
200-day moving average 331.04

Share statistics

Avg vol (3-month) 32.03M
Avg vol (10-day) 31.57M
Shares outstanding 5158.03M
Implied shares outstanding 6158.03M
Float 850.68M
% held by insiders 156.16%
% held by institutions 117.10%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 43.82%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4442.48%
Dividend date 3N/A
Ex-dividend date 429 May 2023
Last split factor 21.3:1
Last split date 301 June 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.07%
Operating margin (ttm)12.03%

Management effectiveness

Return on assets (ttm)1.26%
Return on equity (ttm)1.34%

Income statement

Revenue (ttm)1.16B
Revenue per share (ttm)7.36
Quarterly revenue growth (yoy)-7.20%
Gross profit (ttm)N/A
EBITDA 105.27M
Net income avi to common (ttm)35.7M
Diluted EPS (ttm)0.22
Quarterly earnings growth (yoy)-49.00%

Balance sheet

Total cash (mrq)1.58B
Total cash per share (mrq)9.99
Total debt (mrq)256.21M
Total debt/equity (mrq)12.39%
Current ratio (mrq)9.63
Book value per share (mrq)13.12

Cash flow statement

Operating cash flow (ttm)145.81M
Levered free cash flow (ttm)145.59M